2016
Pre-diagnostic Sleep Duration and Sleep Quality in Relation to Subsequent Cancer Survival.
Phipps AI, Bhatti P, Neuhouser ML, Chen C, Crane TE, Kroenke CH, Ochs-Balcom H, Rissling M, Snively BM, Stefanick ML, Treggiari MM, Watson NF. Pre-diagnostic Sleep Duration and Sleep Quality in Relation to Subsequent Cancer Survival. Journal Of Clinical Sleep Medicine 2016, 12: 495-503. PMID: 26612513, PMCID: PMC4795275, DOI: 10.5664/jcsm.5674.Peer-Reviewed Original ResearchMeSH KeywordsAgedFemaleHumansLongitudinal StudiesMiddle AgedNeoplasmsProportional Hazards ModelsRisk FactorsSleepSleep Wake DisordersSnoringSurvivorsTime FactorsConceptsWomen's Health InitiativeShort sleep durationSleep characteristicsHazard ratioCancer survivalCancer sitesSleep durationHealth initiativesPrimary invasive cancerCancer-specific survivalConfidence intervalsPoor sleep qualityFrequent snoringStudy armsCox regressionCancer outcomesInvasive cancerCommon cancerWHI participantsPhysical activitySleep qualityElevated riskCancer typesCancerMarital status
2011
Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children With Cystic Fibrosis
Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, Williams J, Hiatt P, Gibson RL, Spencer T, Orenstein D, Chatfield BA, Froh DK, Burns JL, Rosenfeld M, Ramsey BW, Investigators F. Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children With Cystic Fibrosis. JAMA Pediatrics 2011, 165: 847-856. PMID: 21893650, PMCID: PMC3991697, DOI: 10.1001/archpediatrics.2011.136.Peer-Reviewed Original ResearchConceptsPseudomonas aeruginosa infectionCulture-based therapyCulture-based groupsCystic fibrosisAeruginosa infectionEarly Pseudomonas aeruginosa infectionTobramycin inhalation solutionPrimary end pointRate of exacerbationsExacerbation rateIntravenous antibioticsOral ciprofloxacinOral placeboAntibiotic regimensPulmonary exacerbationsAdverse eventsTreat analysisMulticenter trialAntipseudomonal treatmentInhalation solutionOdds ratioComparative efficacyPlaceboEnd pointFibrosis